BMY - Bristol-Myers Squibb Company

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
24,173,000
22,561,000
20,776,000
19,427,000
16,560,000
Cost of Revenue
7,336,000
6,547,000
6,066,000
4,946,000
3,909,000
Gross Profit
16,837,000
16,014,000
14,710,000
14,481,000
12,651,000
Operating Expenses
Research Development
5,441,000
6,345,000
6,411,000
4,940,000
5,920,000
Selling General and Administrative
4,473,000
4,551,000
4,849,000
5,002,000
5,001,000
Total Operating Expenses
9,914,000
10,896,000
11,260,000
9,942,000
10,921,000
Operating Income or Loss
6,923,000
5,118,000
3,450,000
4,539,000
1,730,000
Interest Expense
425,000
183,000
196,000
167,000
184,000
Total Other Income/Expenses Net
111,000
1,075,000
1,877,000
1,543,000
621,000
Income Before Tax
6,609,000
6,010,000
5,131,000
5,915,000
2,167,000
Income Tax Expense
931,000
1,031,000
4,156,000
1,408,000
477,000
Income from Continuing Operations
5,678,000
4,979,000
975,000
4,507,000
1,690,000
Net Income
5,655,000
4,952,000
1,007,000
4,457,000
1,624,000
Net Income available to common shareholders
5,655,000
4,952,000
1,007,000
4,457,000
1,624,000
Reported EPS
Basic
-
3.03
0.61
2.67
0.97
Diluted
-
3.03
0.61
2.65
0.97
Weighted average shares outstanding
Basic
-
1,633,000
1,645,000
1,671,000
1,667,000
Diluted
-
1,637,000
1,652,000
1,680,000
1,679,000
EBITDA
-
6,193,000
6,116,000
6,082,000
2,351,000